Jan 30, 2020
A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each. The company has managed to net USD 2 million more by offering 40% more shares. The company plans to use the funds raised to address the unmet needs in the Alzheimer’s disease market...
Read More...
Oct 16, 2019
Down Syndrome Awareness Month Every year, October is observed as World Down Syndrome awareness month, aiming to aware the general population about Down syndrome. It is a genetic disorder, also known as Trisomy 21 that is caused by the presence of partial or complete of a third copy of a chromosome 21. The early ...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper